Annual Total Liabilities
$1.74 M
-$333.20 K-16.06%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual total liabilities is $1.74 million, with the most recent change of -$333.20 thousand (-16.06%) on December 31, 2023.
- During the last 3 years, BGLC annual total liabilities has fallen by -$1.71 million (-49.56%).
- BGLC annual total liabilities is now -49.56% below its all-time high of $3.45 million, reached on December 1, 2020.
Performance
BGLC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.61 M
+$12.90 K+0.81%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly total liabilities is $1.61 million, with the most recent change of +$12.90 thousand (+0.81%) on September 30, 2024.
- Over the past year, BGLC quarterly total liabilities has increased by +$12.90 thousand (+0.81%).
- BGLC quarterly total liabilities is now -53.47% below its all-time high of $3.45 million, reached on December 1, 2020.
Performance
BGLC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BGLC Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.1% | +0.8% |
| 3 y3 years | -49.6% | -1.4% |
| 5 y5 years | +1236.8% | -1.4% |
BGLC Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.3% | at low | -32.9% | +16.9% |
| 5 y | 5-year | -49.6% | +1499.5% | -53.5% | +1869.2% |
| alltime | all time | -49.6% | +1499.5% | -53.5% | +1869.2% |
BioNexus Gene Lab Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.61 M(+0.8%) |
| Jun 2024 | - | $1.59 M(-12.3%) |
| Mar 2024 | - | $1.82 M(+4.3%) |
| Dec 2023 | $1.74 M(-16.1%) | $1.74 M(-2.0%) |
| Sep 2023 | - | $1.78 M(-8.1%) |
| Jun 2023 | - | $1.94 M(+18.7%) |
| Mar 2023 | - | $1.63 M(-21.5%) |
| Dec 2022 | $2.08 M(-13.3%) | $2.08 M(+51.0%) |
| Sep 2022 | - | $1.37 M(-11.1%) |
| Jun 2022 | - | $1.55 M(-24.4%) |
| Mar 2022 | - | $2.05 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.39 M(-30.7%) | - |
| Dec 2021 | - | $2.39 M(-11.7%) |
| Sep 2021 | - | $2.71 M(+3.0%) |
| Jun 2021 | - | $2.63 M(-15.2%) |
| Mar 2021 | - | $3.11 M(-10.0%) |
| Dec 2020 | $3.45 M(+3070.9%) | $3.45 M(+4131.7%) |
| Sep 2020 | - | $81.60 K(-9.9%) |
| Jun 2020 | - | $90.60 K(-3.8%) |
| Mar 2020 | - | $94.20 K(-13.5%) |
| Dec 2019 | $108.90 K(-16.4%) | $108.90 K |
| Dec 2018 | $130.30 K | - |
FAQ
- What is BioNexus Gene Lab annual total liabilities?
- What is the all time high annual total liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual total liabilities year-on-year change?
- What is BioNexus Gene Lab quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly total liabilities year-on-year change?
What is BioNexus Gene Lab annual total liabilities?
The current annual total liabilities of BGLC is $1.74 M
What is the all time high annual total liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual total liabilities is $3.45 M
What is BioNexus Gene Lab annual total liabilities year-on-year change?
Over the past year, BGLC annual total liabilities has changed by -$333.20 K (-16.06%)
What is BioNexus Gene Lab quarterly total liabilities?
The current quarterly total liabilities of BGLC is $1.61 M
What is the all time high quarterly total liabilities for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly total liabilities is $3.45 M
What is BioNexus Gene Lab quarterly total liabilities year-on-year change?
Over the past year, BGLC quarterly total liabilities has changed by +$12.90 K (+0.81%)